The specific inhibition of STAT3 is important for treating cancer cells because certain growth suppressive cytokines, such as IFN-γ, activates STAT1, which mediates growth suppressive signals [45], as well as STAT3, which promotes cell growth [46]. This evidence concerns the gene IFNG and cancer.